111, Inc. Announces Change to Board of Directors

Core Viewpoint - 111, Inc. announced the resignation of Dr. Leon Lian Yong Chen from its board of directors and the appointment of Mr. Yang "Luke" Chen as a new director, effective November 4, 2024, highlighting a transition in leadership that aims to strengthen the company's strategic initiatives in the healthcare sector [1][2][3]. Group 1: Leadership Changes - Dr. Leon Lian Yong Chen has served on the board since May 2019 and has made significant contributions to the company's goals and strategies [2]. - Mr. Yang "Luke" Chen, currently the Senior Finance Executive, has been appointed as a new director, bringing extensive financial expertise and a deep understanding of the business [3]. Group 2: Company Overview - 111, Inc. is a tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [4]. - The company provides better access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4]. - 111, Inc. also offers online healthcare services via its internet hospital, 1 Clinic, which includes online consultations and electronic prescriptions [4].